1110059M19Rik Activators
The chemical class designated as "1110059M19Rik" represents a unique set of compounds characterized by their ability to modulate biochemical pathways within cells. These compounds are distinguished by their molecular structures, which enable them to interact with specific cellular components, leading to a cascade of biochemical events. The precise nature of these interactions is grounded in the affinity and specificity that the compounds exhibit towards their molecular targets. For example, through the elevation of intracellular cyclic AMP (cAMP) levels, certain members of this class can activate protein kinase A (PKA). Once activated, PKA can phosphorylate a variety of substrates, including proteins that are central to cellular signaling networks. This phosphorylation serves as a molecular switch, altering the functional state of the protein substrates and thereby modulating the signaling pathways in which they are involved.
Furthermore, the chemical class "1110059M19Rik" includes activators that can directly influence the activity of protein kinase C (PKC). The interaction between PKC activators and the kinase is a direct one, with the activators binding to the regulatory region of PKC, prompting a conformational change that leads to its activation. Upon activation, PKC can phosphorylate its substrates, which can include various proteins that play pivotal roles in cellular signaling. In addition to cAMP and PKC pathways, this chemical class encompasses compounds that can elevate intracellular calcium levels. Such an increase in calcium can activate a suite of calcium-dependent protein kinases, which, in turn, can phosphorylate a range of intracellular targets. The precise molecular interactions and cellular consequences of activating these kinases depend on the context of the cell type and the physiological state. In summary, "1110059M19Rik" represents a class of biochemical modulators with defined molecular actions that can exert influence over key signaling pathways within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP in cells, indirectly increasing their levels and possibly leading to enhanced activation of 1110059M19Rik through cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC), which can modify various proteins and signaling pathways, potentially enhancing the activity of 1110059M19Rik through phosphorylation mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a polyphenol found in green tea that has been shown to inhibit certain types of protein kinases, which might reduce competitive signaling and indirectly enhance the activity of 1110059M19Rik by altering kinase cascades. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) is a bioactive lipid that activates sphingosine-1-phosphate receptors and can modulate a variety of signaling pathways, potentially leading to the activation of 1110059M19Rik through altered receptor-mediated signaling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K, which can lead to altered signaling downstream of PI3K, potentially enhancing activities of proteins like 1110059M19Rik that may be modulated by PI3K-Akt pathway alterations. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels, which can activate calcium-dependent signaling pathways, possibly leading to the enhanced activity of 1110059M19Rik through calcium signaling modulation. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor that can reduce competitive signaling and thus may enhance pathways in which 1110059M19Rik is involved by shifting the balance of tyrosine kinase-dependent signaling. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of MEK, which affects the MAPK/ERK pathway. By inhibiting this pathway, it may indirectly enhance the functions of 1110059M19Rik through alternative signaling routes. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, potentially enhancing the activity of 1110059M19Rik through calcium-dependent signaling pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAPK, altering the MAPK pathway signaling. This may lead to the activation of 1110059M19Rik by shifting signaling through alternative routes that are p38 MAPK independent. | ||||||